<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: An increase in endogenous <z:chebi fb="105" ids="17234">glucose</z:chebi> production (EGP) is a major contributor to fasting morning <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>This increase is dissipated with fasting, later in the day </plain></SENT>
<SENT sid="2" pm="."><plain>To understand its origin, EGP, gluconeogenesis and hormones that regulate metabolism were measured over 24 h </plain></SENT>
<SENT sid="3" pm="."><plain>We hypothesised that EGP, and therefore glycaemia, would demonstrate a centrally mediated circadian rhythm in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>SUBJECTS AND METHODS: Seven subjects with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and six age- and BMI-matched control subjects, fasting after breakfast (08.00 h), underwent a further 24-h fast, with the infusion of [U-(13)C]<z:chebi fb="105" ids="17234">glucose</z:chebi> and [3-(14)C]<z:chebi fb="4" ids="24996">lactate</z:chebi>, starting at 14.00 h </plain></SENT>
<SENT sid="5" pm="."><plain>The MCR and production of total and gluconeogenic <z:chebi fb="105" ids="17234">glucose</z:chebi> were determined from the tracer concentrations using compartmental analysis </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: MCR was near constant: 1.73+/-0.10 in control and 1.40+/-0.14 ml kg(-1) min(-1) in diabetic subjects (p=0.04) </plain></SENT>
<SENT sid="7" pm="."><plain>EGP in <z:mp ids='MP_0002055'>diabetes</z:mp> rose gradually overnight from 8.2+/-0.7 to 11.3+/-0.5 micromol kg(-1) min(-1) at 06.00 h (p&lt;0.05) </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi> utilisation lagged EGP, rising from 8.5+/-0.6 to 10.5+/-0.4 micromol kg(-1) min(-1) (p&lt;0.05), inducing a fall in glycaemia from a peak of 8.0+/-0.5 mmol/l to 6.3+/-0.4 mmol/l (p&lt;0.05) </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="1" ids="17650">Cortisol</z:chebi> and <z:chebi fb="9" ids="16796">melatonin</z:chebi> showed diurnal variations, whereas insulin, glucagon and leptin did not </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="9" ids="16796">Melatonin</z:chebi> was most closely related to EGP, but its secretion was attenuated in <z:mp ids='MP_0002055'>diabetes</z:mp> (p&lt;0.05) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS/INTERPRETATION: In type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, EGP and gluconeogenesis display diurnal rhythms that drive the fasting <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> and are absent in healthy control subjects </plain></SENT>
<SENT sid="12" pm="."><plain>The rise in EGP may be related to a deficit in suprachiasmatic nucleus activity in <z:mp ids='MP_0002055'>diabetes</z:mp>, or result from non-linear behaviour plus a transition from a <z:mpath ids='MPATH_458'>normal</z:mpath> steady state to a limit cycle pattern in <z:mp ids='MP_0002055'>diabetes</z:mp>, or both </plain></SENT>
</text></document>